• $601.9M
    Market Cap
  • 51.72%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
25,000
-79.95%
124,666
+15.00%
108,406
+19.54%
90,683
+32.17%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
25,000
-79.95%
124,666
+15.00%
108,406
+19.54%
90,683
+32.17%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-126.8M
-28.07%
-176.3M
+44.38%
-122.1M
+55.27%
-78.7M
+203.78%
Depreciation and Amortization Expense
7,000
-62.76%
18,799
+10.58%
17,001
+42.66%
11,917
-20.62%
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
-155.8M
-18.81%
-191.8M
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-46.5M
+53.51%
-30.3M
+124.80%
-13.5M
N/A
N/A
N/A
Interest Income and Expense and Net
-46.5M
+53.51%
-30.3M
+124.80%
-13.5M
N/A
0
N/A
Total Nonoperating Income and Expense
46.5M
+53.51%
30.3M
+124.80%
13.5M
+12,327.91%
108,322
-72.85%
Income before Taxes
-162.8M
-26.09%
-220.2M
+54.53%
-142.5M
+53.55%
-92.8M
+104.69%
Income Taxes
-6.9M
-26.19%
-9.4M
+58.82%
-5.9M
-5.92%
-6.3M
+27.55%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-162.8M
-26.09%
-220.2M
+54.53%
-142.5M
+53.55%
-92.8M
+104.69%
Net Income from Continuing Operations Applicable to Common
-162.8M
-26.09%
-220.2M
+54.53%
-142.5M
+53.55%
-92.8M
+104.69%
Basic EPS and Net Income
-0.13
-61.49%
-0.35
+7.17%
-0.32
N/A
N/A
N/A
Diluted EPS and Net Income
-0.13
-61.49%
-0.35
+7.17%
-0.32
N/A
N/A
N/A
Basic Weighted Average Shares
1.2B
+91.90%
638.2M
+44.18%
442.6M
+25.91%
351.6M
+9.71%
Diluted Weighted Average Shares
1.2B
+91.90%
638.2M
+44.18%
442.6M
+25.91%
351.6M
+9.71%
Balance Sheet
Cash and Cash Equivalents
19.3M
-88.81%
172.5M
+93.38%
89.2M
+99.83%
44.6M
-62.24%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
19.3M
-88.81%
172.5M
+93.38%
89.2M
+99.83%
44.6M
-62.24%
Total Current Assets
56.8M
-69.82%
188.2M
+91.28%
98.4M
+64.23%
59.9M
-56.63%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
0
-100.00%
47,725
+44.47%
33,035
+17.64%
28,082
+20.74%
Total Long-Term Assets
0
-100.00%
598,652
+134.75%
255,021
+84.29%
138,377
-52.55%
Total Assets
56.8M
-69.91%
188.8M
+91.39%
98.6M
+64.27%
60.0M
-56.62%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
9.7M
-74.42%
38.1M
+113.30%
17.8M
+56.49%
11.4M
+371.61%
Total Current Liabilities
257.9M
+302.57%
64.1M
+241.76%
18.7M
+55.65%
12.0M
+287.63%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
200.5M
+133.87%
85.8M
+306,441.28%
27,974
+65.38%
Total Liabilities
257.9M
-2.54%
264.6M
+153.22%
104.5M
+765.76%
12.1M
+286.43%
Retained Earnings
-742.5M
+28.08%
-579.7M
+61.27%
-359.5M
+65.70%
-216.9M
+74.78%
Total Stockholders Equity
-201.1M
+165.23%
-75.8M
+1,195.20%
-5.9M
-112.20%
48.0M
-64.54%
Total Shares Outstanding
497,488
-99.89%
466.1M
+376.45%
97.8M
-72.22%
352.2M
+0.33%
Cash Flow
Cash from Operating Activities
-158.6M
-1.47%
-161.0M
+33.50%
-120.6M
+69.07%
-71.3M
+56.62%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-13,000
-61.18%
-33,489
+52.54%
-21,954
+29.83%
-16,910
-102.58%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
34.8M
-85.74%
243.7M
+45.70%
167.3M
+97,387.20%
171,597
-99.85%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-623,048.00%
+304.88%
-153,885.37%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-132.57%
-13.49%
-153.25%
-14.68%
-179.62%
+92.03%
-93.54%
N/A
Return on Equity
117.59%
-78.20%
539.39%
+179.71%
-676.67%
+568.03%
-101.29%
N/A
Revenue Growth
-79.95%
-633.00%
15.00%
-23.25%
19.54%
-39.24%
32.17%
N/A
Current Ratio
0.22
-92.50%
2.94
-44.03%
5.25
+5.51%
4.98
N/A
Cash Ratio
0.07
-97.22%
2.69
-43.42%
4.76
+28.39%
3.71
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow